首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18737篇
  免费   3391篇
  国内免费   4556篇
化学   13615篇
晶体学   491篇
力学   1236篇
综合类   523篇
数学   2660篇
物理学   8159篇
  2024年   58篇
  2023年   322篇
  2022年   690篇
  2021年   671篇
  2020年   676篇
  2019年   712篇
  2018年   662篇
  2017年   791篇
  2016年   784篇
  2015年   947篇
  2014年   1080篇
  2013年   1459篇
  2012年   1514篇
  2011年   1603篇
  2010年   1387篇
  2009年   1335篇
  2008年   1609篇
  2007年   1410篇
  2006年   1353篇
  2005年   991篇
  2004年   872篇
  2003年   688篇
  2002年   710篇
  2001年   647篇
  2000年   677篇
  1999年   520篇
  1998年   315篇
  1997年   241篇
  1996年   243篇
  1995年   200篇
  1994年   192篇
  1993年   219篇
  1992年   175篇
  1991年   146篇
  1990年   142篇
  1989年   115篇
  1988年   86篇
  1987年   94篇
  1986年   60篇
  1985年   62篇
  1984年   43篇
  1983年   38篇
  1982年   31篇
  1981年   20篇
  1980年   19篇
  1979年   22篇
  1978年   11篇
  1977年   8篇
  1976年   7篇
  1975年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
Supercharged proteins are a new class of functional proteins with exceptional stability and potent ability to deliver bio‐macromolecules into cells. As a proof‐of‐principle, a novel application of supercharged proteins as a versatile biosensing platform for nucleic acid detection and epigenetics analysis is presented. Taking supercharged green fluorescent protein (ScGFP) as the signal reporter, a simple turn‐on homogenous method for DNA detection has been developed based on the polyionic nanoscale complex of ScGFP/DNA and toehold strand displacement. This assay shows high sensitivity and potent ability to detect single‐base mismatch. Furthermore, combined with bisulfite conversion, this ScGFP‐based assay was further applied to analyze site‐specific DNA methylation status of genomic DNA extracted from real human colon carcinoma tissue sample with ultrahigh sensitivity (4 amol methylated DNA).  相似文献   
982.
Chemically induced dimerization (CID) has proven to be a powerful tool for modulating protein interactions. However, the traditional dimerizer rapamycin has limitations in certain in vivo applications because of its slow reversibility and its affinity for endogenous proteins. Described herein is a bioorthogonal system for rapidly reversible CID. A novel dimerizer with synthetic ligand of FKBP′ (SLF′) linked to trimethoprim (TMP). The SLF′ moiety binds to the F36V mutant of FK506‐binding protein (FKBP) and the TMP moiety binds to E. coli dihydrofolate reductase (eDHFR). SLF′‐TMP‐induced heterodimerization of FKBP(F36V) and eDHFR with a dissociation constant of 0.12 μM . Addition of TMP alone was sufficient to rapidly disrupt this heterodimerization. Two examples are presented to demonstrate that this system is an invaluable tool, which can be widely used to rapidly and reversibly control protein function in vivo.  相似文献   
983.
BRCTs are phosphoserine‐binding domains found in proteins involved in DNA repair, DNA damage response and cell cycle regulation. BRCA1 is a BRCT domain‐containing, tumor‐suppressing protein expressed in the cells of breast and other human tissues. Mutations in BRCA1 have been found in ca. 50 % of hereditary breast cancers. Cell‐permeable, small‐molecule BRCA1 inhibitors are promising anticancer agents, but are not available currently. Herein, with the assist of microarray‐based platforms, we have discovered the first cell‐permeable protein–protein interaction (PPI) inhibitors against BRCA1. By targeting the (BRCT)2 domain, we showed compound 15 a and its prodrug 15 b inhibited BRCA1 activities in tumor cells, sensitized these cells to ionizing radiation‐induced apoptosis, and showed synergistic inhibitory effect when used in combination with Olaparib (a small‐molecule inhibitor of poly‐ADP‐ribose polymerase) and Etoposide (a small‐molecule inhibitor of topoisomerase II). Unlike previously reported peptide‐based PPI inhibitors of BRCA1, our compounds are small‐molecule‐like and could be directly administered to tumor cells, thus making them useful for future studies of BRCA1/PARP‐related pathways in DNA damage and repair response, and in cancer therapy.  相似文献   
984.
The chiral RhI–diene‐catalyzed asymmetric three‐component reaction of aryldiazoacetates, aromatic amines, and β‐nitroacrylates was achieved to obtain γ‐nitro‐α‐amino‐succinates in good yields and with high diastereo‐ and enantioselectivity. This reaction is proposed to proceed through the enantioselective trapping of RhI‐associated ammonium ylides by nitroacrylates. This new transformation represents the first example of RhI‐carbene‐induced ylide transformation.  相似文献   
985.
The copper complex [(bztpen)Cu](BF4)2 (bztpen=N‐benzyl‐N,N′,N′‐tris(pyridin‐2‐ylmethyl)ethylenediamine) displays high catalytic activity for electrochemical proton reduction in acidic aqueous solutions, with a calculated hydrogen‐generation rate constant (kobs) of over 10000 s?1. A turnover frequency (TOF) of 7000 h?1 cm?2 and a Faradaic efficiency of 96 % were obtained from a controlled potential electrolysis (CPE) experiment with [(bztpen)Cu]2+ in pH 2.5 buffer solution at ?0.90 V versus the standard hydrogen electrode (SHE) over two hours using a glassy carbon electrode. A mechanism involving two proton‐coupled reduction steps was proposed for the dihydrogen generation reaction catalyzed by [(bztpen)Cu]2+.  相似文献   
986.
Higher catalytic performances of N,N′,N′′‐trihydroxyisocyanuric acid (THICA), N,N‐dihydroxypyromellitimide (NDHPI), and N‐hydroxynaphthalimide (NHNI) than that of N‐hydroxyphthalimide (NHPI) have been demonstrated recently in aerobic oxidation. Herein, the rational design of reactive multi‐nitroxyl organocatalysts has been addressed theoretically by using systematic analysis of some important properties and catalytic activities of yet‐to‐be‐synthesized catalysts. Our results show that 1) NHNI and its analogue, similar to THICA, unlike NHPI and others, are unsuitable for solvent‐ or mediator‐free catalysis due to their strong intramolecular hydrogen‐bonding interactions; 2) increasing the reactive hydroxyimide groups on the same aromatic ring, or doped N atoms or ionic‐pair groups onto the aromatic ring, can improve catalytic reactivity, whereas appropriate enlargement of conjugated aromatic systems results in unchanged activity; 3) the newly designed catalysts are more active than NHPI and NHNI and have catalytic activities comparable to NDHPI and THICA; 4) the ionic‐pair supported case is suggested to be a very active catalyst, even towards inert propane, and can be used as a novel model catalyst for further improvements. The present work will be helpful in designing reactive hydroxyimide organocatalysts.  相似文献   
987.
取均质后的桃皮或桃肉,在匀浆机上用乙腈提取;加入氯化钠及硫酸镁振荡盐析;取上清液与PSA混匀并离心进行净化。取经滤膜过滤的滤液与水混匀后供液相色谱-串联质谱分析。用Agilent Eclipse plus C18 RRHT色谱柱为分离柱,用含甲酸的5mmol·L-1甲酸铵溶液与乙腈以不同比例的混合液作流动相进行梯度淋洗。质谱测定中采用电喷雾正离子源动态多反应监测模式进行检测。所测31种农药在一定质量分数范围内保持线性关系,方法的检出限(3S/N)在0.04~20μg·kg-1之间,回收率在73.6%~119%之间,测定值的相对标准偏差(n=6)在0.70%~17%之间。  相似文献   
988.
提出了反相高效液相色谱法同时测定壮阳类保健品中4种PDE5抑制剂和达泊西汀含量的方法。样品溶于水中,再加甲醇提取。分取10μL提取液进样,并用Inertsil ODS-SP色谱柱为分离柱和由(A)三乙胺-乙酸-水(8+4+988)混合液,(B)乙腈和(C)0.02%(φ)磷酸溶液三者按不同比例相混的混合液作流动相进行梯度淋洗和分离。在检测波长290nm处进行测定。他达那非的质量浓度在1.25~25.0mg·L-1范围内与其峰面积呈线性关系,其余4种化合物的质量浓度在5.0~100mg·L-1范围内与其峰面积呈线性关系,方法的检出限(3S/N)在0.05~0.2mg·L-1之间。加标回收率在94.1%~109%之间,测定值的相对标准偏差(n=6)均小于1.0%。  相似文献   
989.
通过低温溶剂热的方法成功制备出了LiCr0.2Ni0.4Mn1.4O4尖晶石正极材料。通过此法,溶液的饱和蒸汽压急剧降低且在室温(25℃)下即可沸腾。所有的金属离子可在随后的热聚合过程中均匀分散且煅烧后所得材料无杂质相生成。采用了热重分析,X射线衍射,扫描电镜、循环伏安,交流阻抗等测试手段对材料进行了表征。结果表明:此法所得材料含有Mn3+,为Fd3m晶型,且其形貌规则、粒度分布均一。1C和10C下放电容量为140.5和121.0 mAh·g-1,10C下100次循环容量保持率高达96.9%。其优异的电化学性能可归因于均相的前驱体制备过程,高结晶度且无杂相生成,以及较高的锂离子扩散系数诸因素的共同作用。  相似文献   
990.
A sensitive fluorescent probe, 2,2'-bisbenzimidazole (L), for CN has been developed. This structurally simple receptor displays great selectivity for the cyanide anion over other common inorganic anions in an aqueous environment. In addition, further study demonstrates the lower detection of the fluorescence response of the sensor to CN is in 10 9 mol/L range. Thus, the present probe should be applicable as a practical system for the monitoring of cyanide concentrations in aqueous samples.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号